FDA Approves NovaBone MacroFORM MIS Delivery System

The FDA has approved NovaBone Products’ MacroFORM MIS Delivery System for use in minimally invasive orthopedic procedures.

The system — developed for surgeons who require controlled and precise delivery of bone grafting material to not readily accessible surgical sites — facilitates absorption of bone marrow aspirate by mixing with bone marrow to yield a porous scaffold that facilitates bone growth.

Based in Jacksonville, Fla., NovaBone focuses on bioactive glass design and manufacturing. — Michael Cipriano